Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo’s Avandia Has More Heart Risks Than Actos, Study Finds
Glaxo’s Avandia Has More Heart Risks Than Actos, Study Finds
Glaxo’s Avandia Has More Heart Risks Than Actos, Study Finds
Submitted by
admin
on August 19, 2009 - 6:23am
Source:
Bloomberg
News Tags:
GSK
Actos
Avandia
diabetes
Takeda
Headline:
Glaxo’s Avandia Has More Heart Risks Than Actos, Study Finds
Do Not Allow Advertisers to Use My Personal information
